openPR Logo
Press release

Europe Molecular Diagnostics Market Poised to Garner Maximum Revenues During 2025

11-10-2017 11:05 AM CET | Health & Medicine

Press release from: TMR - Research Reports

Europe Molecular Diagnostics Market Poised to Garner Maximum

As per a report by Transparency Market Research, the Europe molecular diagnostics market will likely rise at a steady CAGR of 6.6% during the period between 2017 and 2025. At this rate, the market will become worth US$769.0 mn by 2025-end from US$395.7 mn in 2016.

The different types of product in the market for molecular diagnostics in Europe are real-time PCR systems, liquid handling systems, and DNA extraction systems. Of them, the real-time PCR systems accounts for maximum market share and going forward too will likely dominate the market owing to a range of advantages over conventional PCR systems.

Read Report Overview @ https://www.transparencymarketresearch.com/europe-molecular-diagnostics-market.html

From a geographical standpoint, the key segments of the of the Europe molecular diagnostics market are France, the U.K., Germany, Spain, and Italy. Germany, among them, leads vis-à-vis revenue and in the near future too will retain its leading position in this aspect. This is mainly on account on the increased investment of the government in the domain of healthcare, the thrust on bolstering the biotechnology sector, and the growing number of biotechnology companies in the country.

The market for molecular diagnostics in Europe has seen steady progress so far on the back of an ever-increasing healthcare expenditure. Besides, rising awareness about different chronic diseases and disorders, abundant availability of diagnostic centers, and increasing affordability of diagnostics are also serving to catalyze growth in the market. Rising support from the government and growing investments in research and development of advanced diagnostics are also positively influencing the market.

Request Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=9434

A noticeable trend in the Europe market for molecular diagnostics is the move toward automation. In fact, quite a few automated products, particularly in the area of automated liquid handling systems has been launched and are predicted to boost sales in the market in the upcoming years.

Currently, the pharmaceutical and biotechnology companies are resulting in maximum demand in the market because of substantial amounts being poured into research that has generated the need for molecular diagnostic devices.

Posing a hindrance to the molecular diagnostics market in Europe is the shortage of skilled labor, which makes it tough for companies to control costs. Further, the constant thrust on new and improved technologies is also predicted to thwart market growth. Take, for example, the surging popularity of next generation sequencing (NGS) which is snipping away the market share of real-time PCR systems. However, the demand for non-contact dispensing technologies stoking sales of liquid dispensing systems, will likely help the market overcome the challenge.

Request Europe Molecular Diagnostics Market Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=9434

The market for molecular diagnostics in Europe is slated to see competition increase in the near future as companies focus on research and development to come up with better products. With product differentiations and customizations they are attempting to increase their sales and revenues. To that end they are partnering or collaborating with research institute. Dominant players are also focusing on mergers and acquisitions to increase their market share.

Some of the key players in Europe molecular diagnostics market are Agilent Technologies, Inc., Becton, Dickinson and Company, Tecan Group Ltd., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., QIAGEN N.V., Danaher Corporation, Eppendorf AG, PerkinElmer, Inc., and Thermo Fisher Scientific, Inc. Of them, Bio-Rad Laboratories and Thermo Fishcer Scientific accounted for almost half the share in the market in 2016.

Buy Full Europe Molecular Diagnostics Market Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=9434<ype=S

About TMR

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Europe Molecular Diagnostics Market Poised to Garner Maximum Revenues During 2025 here

News-ID: 810895 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Europe

Strategy Consulting Market 2025 | Analysis By Top Key Players: Booz & Co. , Rola …
Global Strategy Consulting Market 2019-2025, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. The key players covered in this study McKinsey , The Boston Consulting Group , Bain & Company , Booz & Co. , Roland Berger Europe
Influenza Vaccination Market Global Forecast 2018-25 Estimated with Top Key Play …
UpMarketResearch published an exclusive report on “Influenza Vaccination market” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 115 pages which highly exhibits on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. This report focuses on the Influenza Vaccination market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This
Global Strategy Consulting Market Research Report 2018-2025 | Global Key Player …
An up-to-date research report has been disclosed by Market Research Hub highlighting the title “Global Strategy Consulting Market Size, Status and Forecast 2018-2025” which provides an outlook for current market value as well as the expected growth of Strategy Consulting during 2018-2025. The report studies the casing heads market worldwide, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, size, growth, revenue, consumption, import and export
Strategy Consulting Market Deep Insights with Core Business Strategies 2018 - Ro …
Strategy Consulting Market report provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consist of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables). Global strategy consulting market size status and forecast 2025 has a vast collection of market research reports concerning the software industry, its sub-sectors, and
Wearable Heart Monitoring Devices Market 2018 To 2023 – Top Leaders Beurer Gmb …
The Worldwide Wearable Heart Monitoring Devices Market is growing at a healthy rate. The major players in this market are Medtronic (U.S.), Kinetec Products UK Ltd. (South America), Beurer GmbH (Europe), Medisana AG (Europe), Briggs Healthcare (U.S.), Polar Electro (Europe), SUUNTO (Europe), Koninklijke Philips N.V. (Europe), Garmin Ltd. (Europe) and others. The Wolrdwide Wearable Heart Monitoring devices is segmented on the basis of products, type, application, and end users. On
Surgical Equipment Market 2018 Leading Manufacturer in Europe, the Middle East & …
The Europe, the Middle East & Africa Surgical Equipment Market is expected to grow at an approximate CAGR of 6.7% during the forecast period. A surgical equipment is a designed tool or device to carry out various surgical procedures so as to modifying biological tissues and to provide access for viewing them. The surgical equipment can be designed specifically for a particular surgery or it can be used as general purpose